熱門資訊> 正文
Elicio Therapeutics任命Preetam Shah为首席财务官
2025-03-24 19:20
- Elicio Therapeutics (NASDAQ:ELTX) said it has appointed Preetam Shah as its chief financial officer and its chief strategy officer.
- Shah had served as the finance chief of Cidara Therapeutics prior to joining Elicio Therapeutics.
More on Elicio Therapeutics
- Elicio: Lymph Node Binding With ELI-002 Could Lead To Substantial 1st Half 2025 Data
- Elicio Therapeutics stock slides on $10M securities offering
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
